Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs). The model, which researchers refer to as a “seizure-in-a-dish” ... Read more
The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial onset epileptic seizures in children as young as 4, making ... Read more
The U.S. Food and Drug Administration has granted expanded approval to LivaNova’s VNS Therapy Systems for people with drug-resistant epilepsy that allows use with magnetic resonance imaging (MRI) of the brain, ... Read more
A multicomponent self-management intervention for adults with epilepsy did not significantly improve disease-related quality of life or other disease-related measures compared to usual care in a clinical trial. Nevertheless, ... Read more
Researchers have, for the first time, showed that it is possible to stimulate structures deep within the brain without the need for implanted electrodes — opening the possibility that epilepsy patients ... Read more
A medical cannabis product called RSHO-X dramatically reduced epileptic seizures in a Mexican study of Lennox-Gastaut syndrome, a severe form of childhood epilepsy that responds poorly to treatment. The ... Read more
Not only abnormal stimulation kills brain neurons in epilepsy, new research shows. It appears that lack of oxygen caused by blood flow abnormalities triggers up to half of nerve cell ... Read more